The market showed a negative development Tuesday, and UK 100 (CBOE) ended the day at 821 points, which is a decline of 0.6 percent. 620 shares showed a gain and 1126 showed a loss. 156 shares were unchanged and closed at the same price as the previous day. There was no trading in 216 shares. Total value of the trading volume for shares and primary capital certificates Tuesday was approximately 724.6 billion. | |
AIQ Limited | 140.00% |
Simec Atlantis Energy Ltd | 114.85% |
SOCIETE GENERALE ACCEPTANC | 90.48% |
Active Energy Group plc | 68.75% |
Libertine Holdings Plc | 62.73% |
SOCIETE GENERALE ACCEPTANC | -55.79% |
SOCIETE GENERALE ACCEPTANC | -48.78% |
SOCIETE GENERALE ACCEPTANC | -44.60% |
SOCIETE GENERALE ACCEPTANC | -40.75% |
SOCIETE GENERALE ACCEPTANC | -36.00% |
AstraZeneca | 44203.24 |
Rolls-Royce Holdings PLC | 43453.94 |
Anglo American PLC | 24339.73 |
Experian PLC | 23125.99 |
BAE Systems PLC | 20015.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.